Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteplxpharma.com
CategoryBioTech
Phone713-842-1249
Emailron.zimmerman@plx...
Employees

Offices

Houston, USA
8285 El Rio
Suite 130
Houston, TX, 77054
USA

People

Founder, Chairman and Chief Executive Officer
Chief Operating Officer (COO) and Director
Chairman and Member of Chief Executive officer of Advisory Group
Scientific Founder
Senior Vice President
Board Chairman
Bord of Directors

Funding

TOTAL $25.3M
FUNDING TOTAL $25.3M
Venture Round, 1/2009
$3.11M
Partial Close, 8/2010
$2M
Partial Close, 10/2011
$2.89M
Venture Round, 3/2013
$8.27M
Venture Round, 7/2013
$9M

Tags

PLx Pharma

PLx Pharma Inc., a pharmaceutical company, develops and commercializes non-steroidal anti-inflammatory drugs (NSAIDs) for prescription and over-the-counter markets in the United States. The company offers PL2200 Aspirin, a molecular complex of aspirin and phosphatidylcholine; and PL1100/1200 Ibuprofen, which are oral drug products containing a molecular complex of ibuprofen and phosphatidylcholine. It also provides other NSAID-PC products, which include PL4500 Indomethacin IV, a molecular complex of indomethacin and phosphatidylcholine that is developed in oral formulations and as an IV formulation for the treatment of PDA; and PL5100 Diclofenac, a molecular complex of diclofenac and phosphatidylcholine that is developed as an oral anti-inflammatory and analgesic drug. The company is based in Houston, Texas.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/7/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy